HCAT Health Catalyst, Inc.
Health Catalyst, Inc. (HCAT) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.09 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.6% since its last earnings release on November 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Health Catalyst, Inc.
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement.
Sector
Technology
Industry
Business Software and Services
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.